Copper toxicity is belevied to be due to fenton-type redox reactions occuring with high copper concentrations which produce damaging reactive oxygen species A19514.
Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase FDA Label. Copper is commonly used in contraceptive intrauterine devices (IUD) L801.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Dehydroascorbic acid | The serum concentration of Dehydroascorbic acid can be decreased when it is combined with Copper. |
| Zinc ascorbate | The serum concentration of Zinc ascorbate can be decreased when it is combined with Copper. |
| Chlorotrianisene | Chlorotrianisene can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Conjugated estrogens | Conjugated estrogens can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Estrone | Estrone can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Estradiol | Estradiol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Dienestrol | Dienestrol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Ethinylestradiol | Ethinylestradiol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Estriol | Estriol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Estrone sulfate | Estrone sulfate can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Quinestrol | Quinestrol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Hexestrol | Hexestrol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Polyestradiol phosphate | Polyestradiol phosphate can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Zeranol | Zeranol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Equol | Equol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Promestriene | Promestriene can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Methallenestril | Methallenestril can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Epimestrol | Epimestrol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Moxestrol | Moxestrol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Estradiol acetate | Estradiol acetate can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Biochanin A | Biochanin A can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Formononetin | Formononetin can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects. |